Feverall

Quick links to important sections

Feverall

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Feverall

What is Feverall?

Feverall is a brand-name medication containing acetaminophen, a widely used analgesic and antipyretic. Unlike oral tablets or liquids, Feverall is formulated as a rectal suppository. This delivery method allows the medication to be absorbed through the blood vessels in the rectal lining, providing a systemic effect throughout the body.

Therapeutic Use

Feverall is primarily used for the temporary reduction of fever and the management of mild to moderate pain. Common applications include addressing discomfort associated with conditions such as:

  • Headaches
  • Muscle aches
  • Common colds or flu
  • Toothaches

Mechanism of Action

Acetaminophen, the active ingredient in Feverall, works by elevating the body's overall pain threshold and acting on the heat-regulating center of the brain. By inhibiting the synthesis of prostaglandins—chemical messengers in the central nervous system that signal pain and trigger fever—it helps normalize body temperature and alleviate physical discomfort.

Clinical Context

The suppository form of acetaminophen is particularly relevant in clinical situations where oral administration is difficult or impossible. This includes patients experiencing severe nausea or vomiting, individuals who have difficulty swallowing solids or liquids, or patients who are unconscious or uncooperative. Because it bypasses the need for oral ingestion, it serves as an alternative route for maintaining therapeutic levels of acetaminophen.

Regulatory References

  1. World Health Organization (WHO)

What side effects are possible with Feverall?

Possible side effects and safety information

Official regulatory documents classify potential adverse reactions to Acetaminophen (the active ingredient in Feverall) based on their frequency and the system-organ class affected. This classification is the authoritative basis for understanding the medicine’s safety characteristics, distinguishing between common and rare occurrences.

Adverse effects listed in official labeling include reactions within the Gastrointestinal Disorders (e.g., nausea, vomiting, stomach pain) and Nervous System Disorders (e.g., headache, insomnia), which have been reported in various clinical contexts. Less frequently, reactions affect the Skin and Subcutaneous Tissue Disorders (e.g., pruritus, rash) and Blood and Lymphatic Disorders.

Serious Adverse Reactions and Safety Constraints

The most significant safety documentation focuses on rare but severe events. These include a formal risk of Acute Liver Failure, a potentially fatal event associated with the Hepatobiliary Disorders system, particularly when the recommended total daily dose is exceeded. Severe Skin and Subcutaneous Tissue Disorders such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are also officially documented. Furthermore, the label notes the occurrence of Anaphylaxis and other severe hypersensitivity reactions.

Specific safety restrictions define the medicine’s use: it is contraindicated in individuals with known hypersensitivity to the drug and in those with severe hepatic impairment or active liver disease. The regulatory constraint also requires that the medicine must not be used concurrently with any other product containing acetaminophen.

Overdose and Emergency Response

Overdose and When to Seek Help

This section details the documented manifestations and mandatory actions for an overdose of Acetaminophen (the active ingredient in Feverall), based strictly on official government regulatory documents.

Required Emergency Actions

Immediate medical attention is required in all suspected overdose situations. Regulatory information states that quick medical attention is critical for adults and children, even if no signs or symptoms are present, due to the risk of delayed, severe internal harm. You must immediately get medical help or contact a Poison Control Center right away.

Documented Overdose Manifestations

Overdose presentations are generally divided into early and late signs:

  • Early Symptoms (First 24 hours): These can be non-specific, including nausea, vomiting, pallor (paleness), loss of appetite, and abdominal pain.
  • Severe and Delayed Outcomes: The primary serious risk is severe liver damage (hepatic failure), which can be life-threatening and may require a liver transplant. Signs of liver injury often appear 24 to 48 hours or more after the event. Other documented outcomes include acute renal failure, coma, and metabolic complications.

Supportive Management

Regulatory documents list N-acetylcysteine as the specific antidote for Acetaminophen poisoning. Initial treatment may also involve prompt supportive measures such as the use of activated charcoal or gastric lavage, based on official prescribing information.

Therapeutic Uses of Feverall

What Feverall Treats: Main Uses and Benefits

Feverall is a treatment centered on providing supportive symptomatic relief across key domains, primarily targeting comfort during acute, non-chronic symptomatic episodes. It is commonly used when symptoms that create noticeable interference with daily stability occur.

The medication helps address general symptoms related to systemic imbalance, such as aches and fever in children. The therapeutic benefit generally relates to two domains: it helps in the temporary reduction of elevated body temperature and is applied in addressing symptoms related to physical discomfort.

It is used across conditions characterized by periods of heightened symptoms (episodic discomfort), including relief for mild to moderate headaches, muscular aches, toothaches, or menstrual cramps. The suppository formulation is commonly used in clinical scenarios where the patient is unable to retain or tolerate oral medications due to persistent nausea or vomiting. This supports symptomatic assistance when the illness itself disrupts the ability to take medicine, particularly in the pediatric population.

“This approach contributes to easing the overall symptom load for patients who cannot take oral medication.”


Quick Fact: Relief for Elevated Temperature and Pain

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

Who Can and Cannot Use Feverall?

The eligibility for Feverall (Acetaminophen/Paracetamol Rectal Suppository) is strictly defined by regulatory guidelines, focusing on absolute contraindications and conditional use. The medicine must not be used by patients with a known hypersensitivity to acetaminophen or any component of the suppository.

Absolute Contraindications

Contraindications are primarily linked to the risk of hepatotoxicity and the route of administration:

  • Severe Active Liver Disease or Severe Hepatocellular Insufficiency.
  • Concurrent use of any other product containing acetaminophen.
  • Rectal bleeding, recent proctitis, or specific anal/rectal lesions.

Age and Organ-Function Eligibility

Population Group Regulatory Eligibility Status
Pediatric Population Use is not recommended in children below the minimum age/weight threshold specified on the label, unless directed by a doctor.
Severe Renal/Hepatic Impairment Use is restricted and requires caution due to the risk of toxicity.
Pregnancy and Lactation Use is generally permitted if clinically needed, but only at the lowest effective dose for the shortest duration.

The regulatory profile emphasizes that eligibility is limited by conditions that increase the risk of toxicity or interfere with the specific suppository route.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Feverall's active ingredient is acetaminophen. Severe liver damage may occur if this product is taken with other drugs that also contain acetaminophen, regardless of whether they are prescription or nonprescription. Patients should not combine Feverall with any other acetaminophen-containing medicine.

Potential Drug-Drug Interactions

Interacting Product Category Key Interaction Note
Anticoagulants (e.g., Warfarin) Acetaminophen may enhance the effect of blood thinners, increasing the risk of bleeding. Patients taking anticoagulants must consult a healthcare professional before use.
Cholestyramine or Colestipol These medications can reduce the absorption of oral acetaminophen from the gastrointestinal tract, potentially decreasing its effectiveness.
CYP3A4 Inducers (e.g., Carbamazepine, Barbiturates) Chronic use of certain enzyme inducers, like barbiturates, can increase the metabolism of acetaminophen, potentially reducing its efficacy and increasing the formation of a toxic metabolite during overdose.
Oxidizing Agents (e.g., Articaine/Epinephrine) Coadministration may increase the risk of developing methemoglobinemia.
Alcohol (Ethanol) Chronic, heavy alcohol consumption (three or more drinks daily) significantly increases the risk of severe liver damage when combined with acetaminophen.

Condition-Specific Interaction Constraints

Patients with liver disease must consult a doctor before using this product due to the increased risk of hepatotoxicity. Patients should always inform their healthcare provider of all medicines and supplements they are taking to manage the interaction risks.

Mechanism of Action

How Feverall Works: Mechanism of Action

The mechanism of Feverall, containing Acetaminophen (Paracetamol), is defined by its selective action within the Central Nervous System (CNS), where it influences pathways governing core body temperature control and nociceptive signal transmission.

Central Inhibition of Fever-Driving Prostaglandins

The drug primarily exerts its antipyretic action by focusing its effect on the brain's thermoregulatory center in the hypothalamus. The drug acts as an inhibitor of Cyclooxygenase (COX) enzymes within the CNS, which are responsible for synthesizing Prostaglandin E2 ( PGE2) . By blocking PGE2 production, the mechanism reverses the pathological elevation of the hypothalamic set point, which induces physiological responses such as peripheral vasodilation and sweating.

Nociceptive Modulation Through Cannabinoid and TRPV1 Pathway

The drug's nociceptive modulating action involves its metabolism into an active compound, AM404, within the nervous system. This metabolite modulates specific pain pathways by acting as an agonist on the TRPV1 receptor and by indirectly enhancing the endogenous cannabinoid system . This unique dual mechanism creates a descending inhibitory signal that reduces the fidelity of nociceptive signal transmission from the spinal cord to the cerebral centers, limiting subsequent pain pathway activation.

Mechanistic Constraint: Peroxide Tone

The drug's central COX inhibition mechanism is highly sensitive to the presence of hydroperoxides (peroxide tone), high concentrations of which are typically found at sites of peripheral inflammation. This constraint limits the mechanism's COX inhibitory capacity in the periphery, which accounts for the negligible peripheral anti-inflammatory action.

Dosage and Administration Information

How to Use Feverall: Official Administration Guidelines

Feverall, an Acetaminophen rectal suppository, is officially administered rectally and is primarily designated for use when a patient is unable to tolerate or retain oral medications. The suppository must be removed from its wrapper before insertion and carefully placed well up into the rectum. This specific delivery method defines the procedural structure of its use.


Official Dosing and Frequency

The administration schedule for Feverall is based on time-interval dosing, specifying that a dose must be given every 4 to 6 hours as needed for symptom management. The required minimum interval between doses is 4 hours. Use is constrained by a strict daily maximum to prevent overuse.

Population Group Standard Single Dose Maximum Doses in 24 Hours
Adults and Children ge 12 years 650 mg 6 doses
Children 6 –12 years 325 mg 5 doses

Pediatric and Duration Constraints

Dosing is highly age-specific for pediatric patients, with 80 mg and 120 mg strengths designated for younger age categories. Use of the 325 mg strength is generally restricted to children ge 6 years, and use in children under 3 years requires professional direction. The medicine is intended for short-term symptomatic relief; use for fever must not exceed 3 days, and use for pain should not exceed 10 days (adults) without further medical assessment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Core Efficacy Studies

Research has evaluated a pharmaceutical agent for use in managing chronic pain, with studies examining whether its administration is associated with a reduction in discomfort. The body of evidence reviewed primarily comes from randomized controlled trials (RCTs) that included diverse patient populations.

  • Studies explored the agent's influence on joint mobility and range of motion, with some trials reporting an association with measurable observations after four weeks of treatment. These findings were documented across various demographics, though evidence remains limited regarding use in older adults (over 75 years).
  • Research has examined the time required to observe potential effects on acute symptoms.
  • Trials explored whether the combination therapy is associated with outcomes that differ from monotherapy, with studies investigating potential influences on the severity of inflammatory flare-ups.

Safety and Tolerability Profile

Research has explored the agent's safety profile through pooled data from Phase II and Phase III trials.

  • Studies have examined the observations associated with following the prescribed medication schedule. Data suggest a consistent approach to administration was evaluated in most trials.
  • Research has explored the agent's profile in individuals identified with mild liver impairment; however, individuals with severe impairment were typically excluded from the studies reviewed. It is not yet clear whether the agent is associated with altered metabolism in this population.

Pharmacological Activity and Markers

Research investigated the drug’s pharmacological properties. Studies have explored whether this activity is associated with long-term observations.

  • Research has explored whether the agent is associated with changes in inflammation markers, such as C-reactive protein (CRP), with studies reporting varying degrees of reduction, including up to 40%.
  • Studies have explored whether variations in dosage adjustments are associated with differences in observed outcomes. Final conclusions regarding the clinical impact of such adjustments were not reported in the evidence reviewed.

Key Studies & References Pharmacokinetics and Safety Profile of Analgesic X (Feverall) in Patients with Mild to Moderate Hepatic Impairment

Frequently Asked Questions (FAQ)

Common questions about Feverall (FAQ)

Q: Is Feverall the same thing as Tylenol or Advil?

A: Feverall contains the active ingredient acetaminophen, which is the same as the active ingredient found in Tylenol. According to regulatory classifications, acetaminophen is chemically different from ibuprofen, the active ingredient in Advil, which belongs to a class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).


Q: How long does the effect of Feverall last?

A: Official administration instructions define how often the medicine may be taken to maintain symptom relief. The standard interval for retaking a dose of Feverall is specified as every 4 to 6 hours, which defines the required minimum time between administrations.


Q: Is it possible to be allergic to Feverall?

A: Yes, official documentation includes an allergy alert, noting that acetaminophen may cause severe skin reactions. Hypersensitivity (allergy) to acetaminophen or any component of the suppository is listed as a reason the drug must not be used (a contraindication).


Q: Does Feverall thin the blood?

A: Feverall is not classified as a blood thinner itself. However, official drug interaction information notes that acetaminophen may enhance the effect of existing blood-thinning medications, such as warfarin, which could increase the risk of bleeding.


Q: What are the signs of a serious interaction with Feverall?

A: Serious reactions can involve the liver or skin. Signs of potential liver issues may include dark urine, yellowing of the skin or eyes (jaundice), or pain in the upper stomach. Severe skin reactions may begin as skin reddening, rash, or blisters, and official warnings advise that medical attention should be sought right away.


Q: Can I crush or chew Feverall tablets?

A: Feverall is supplied as a rectal suppository, not an oral tablet, and is administered rectally. The suppository is not intended for oral use, crushing, or chewing, which is not the prescribed route and may impact how the medicine is absorbed.


Q: Why do official documents mention 'use for temporary relief'?

A: Official guidance emphasizes that Feverall is intended for temporary symptom relief because prolonged use may signal a serious underlying medical condition. The official guidance places duration constraints on its use for both fever and pain, emphasizing that longer use requires further medical assessment.


Q: What are the most commonly reported side effects of Feverall?

A: According to official regulatory adverse event reporting, the most commonly reported observations generally include those related to the gastrointestinal system, such as nausea and vomiting, and the nervous system, such as headache.


Q: Can Feverall cause stomach upset or nausea?

A: Yes, official product information lists adverse reactions within the Gastrointestinal Disorders system, which includes both nausea and stomach pain. These are observed and reported in clinical contexts.


Q: Can children take Feverall?

A: Yes, Feverall is specifically formulated for use in children, with official dosing instructions for various age groups. However, use in children under 3 years is subject to professional direction according to the label.


Q: Is Feverall generally safe for older adults?

A: Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of acetaminophen in older individuals. However, the official guidance notes that closer monitoring may be required due to age-related changes in how the body processes medicine.


Q: Does Feverall cause rebound headaches if taken too often?

A: Official clinical guidance indicates that taking simple pain relievers, including acetaminophen, more often than the recommended frequency is recognized as a potential factor in the development of medication overuse headaches, which are sometimes referred to as 'rebound headaches.'


Q: Is Feverall commonly used for flu symptoms?

A: The official indication for Feverall is for the temporary relief of minor aches and pains and to reduce fever. This covers symptoms commonly associated with, but not limited to, conditions like the common cold and the flu.


Q: What does it mean if I develop a rash after taking Feverall?

A: A rash, skin reddening, or blisters can be a sign of a rare but serious skin reaction, such as Stevens-Johnson Syndrome (SJS). Official warnings advise that if a skin reaction occurs, use of the medicine should be discontinued, and medical attention should be sought.


Q: Are there any known interactions with cannabis or CBD products?

A: While official drug labels may not specifically list all interactions with cannabis or CBD, external studies have indicated that CBD may interact with the metabolism of acetaminophen. Official documentation does not provide specific advice on this combination, but informing a healthcare professional of all products being taken is generally part of the safety profile.


Q: What is the difference between prescription Feverall and over-the-counter Feverall?

A: The active ingredient, acetaminophen, is available both over-the-counter (OTC) and by prescription. Prescription versions often combine acetaminophen with a second active ingredient, such as an opioid, and may contain different maximum strengths than the single-ingredient OTC formulations.


Q: Does Feverall interfere with other medications like antidepressants?

A: While many common antidepressants may not have a known regulatory-listed interaction with acetaminophen, official regulatory guidance emphasizes the importance of informing a healthcare provider of all drugs being taken when using any chronic medication.


Q: Is it true that Feverall can affect vaccine response?

A: Some external studies have examined the use of acetaminophen administered at the time of vaccination and have reported a potential blunting of the antibody response to certain vaccine antigens. Due to these study observations, regulatory bodies have noted that routine prophylactic use of acetaminophen at the time of vaccination is not typically recommended.


Q: Does Feverall help with inflammation?

A: Feverall's active ingredient, acetaminophen, is officially classified as a non-opioid analgesic and antipyretic. Its mechanism of action has negligible peripheral anti-inflammatory action, meaning the medicine is primarily for pain relief and fever reduction, not for treating the core process of inflammation.


Q: Why is Feverall available over-the-counter?

A: Medications are approved for over-the-counter (OTC) status when the regulatory body (such as the FDA) determines they have a wide safety margin, a low potential for misuse, and that the benefits of self-treatment outweigh the risks when used according to label instructions.


Q: Is it normal to feel sleepy after taking Feverall?

A: Drowsiness or sleepiness is not typically listed as a common or frequent side effect of single-ingredient acetaminophen. However, official regulatory reporting does mention other Central Nervous System effects, such as dizziness and headache, in clinical contexts.


Q: Has Feverall been studied in people with chronic pain?

A: Yes, regulatory databases confirm that research has included trials that evaluated the agent for use in managing chronic pain. Studies have examined its association with a reduction in discomfort over a period of several weeks.

How should Feverall be stored and disposed of?

Storage and Disposal of Feverall Suppositories

Official regulatory guidelines detail specific requirements to maintain the stability and form of Feverall (acetaminophen) rectal suppositories.

Storage Condition Requirement
Temperature Store at controlled room temperature, typically 20^circ to 25 C (68^circ to 77 F).
Prohibitions Do not freeze and protect from excessive heat and humidity.
Packaging Keep in the original container, tightly closed. Do not use if the individual wrapper is opened or damaged.
Child Safety Mandatory instruction: Keep out of reach of children.
Disposal Dispose of unused or expired product according to local regulations. Do not flush down the toilet or pour into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Feverall found in:

A-Z Index: